SECOND AMENDMENT TO OFFICE LEASEOffice Lease • November 5th, 2021 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This SECOND AMENDMENT TO OFFICE LEASE ("Second Amendment") is made and entered into as of September 1, 2021, by and between HCP LIFE SCIENCE REIT, INC., a Maryland corporation ("Landlord"), and SORRENTO THERAPEUTICS, INC., a Delaware corporation ("Tenant").
FIRST AMENDMENT TO OFFICE LEASEOffice Lease • November 5th, 2021 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances)
This FIRST AMENDMENT TO OFFICE LEASE ("First Amendment") is made and entered into as of September 14, 2021, by and between HCP LIFE SCIENCE REIT, INC., a Maryland corporation ("Landlord"), and SORRENTO THERAPEUTICS, INC., a Delaware corporation ("Tenant").
FIRST AMENDMENT TO OFFICE LEASEOffice Lease • November 5th, 2021 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances)
This FIRST AMENDMENT TO OFFICE LEASE ("First Amendment") is made and entered into as of October 10, 2020, by and between HCP LIFE SCIENCE ESTATES, INC., a Delaware corporation ("Landlord"), and SORRENTO THERAPEUTICS, INC., a Delaware corporation ("Tenant").
SORRENTO GATEWAY LEASESorrento Gateway • November 5th, 2021 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between HCP LIFE SCIENCE REIT, INC., a Maryland corporation (“Landlord”), and SORRENTO THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
